| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |